Call: 08071793443
Send Inquiry
Send Inquiry150 Mg Nilotinib Capsules
Price 700 INR/ Piece
MOQ : 1 Piece
150 Mg Nilotinib Capsules Specification
- Indication
- Chronic Myeloid Leukemia (CML)
- Salt Composition
- Nilotinib 150 mg
- Dosage Form
- Capsule
- Feature
- Oral targeted therapy
- Ingredients
- Nilotinib hydrochloride monohydrate and excipients
- Application
- Treatment of Philadelphia chromosome positive chronic myeloid leukemia
- Physical Color/Texture
- Opaque yellowish/reddish hard gelatin capsule
- Fermentation Smell
- Odorless
- Storage Instructions
- Store below 30C, keep dry and protected from light
- Shelf Life
- 24 months
About 150 Mg Nilotinib Capsules
Trending worldwide, the acclaimed 150 Mg Nilotinib Capsules deliver optimum results for adults fighting Philadelphia chromosome positive chronic myeloid leukemia (CML). Crafted as a top-notch oral targeted therapy, each capsule contains 150 mg Nilotinib hydrochloride monohydrate for precision. Available at the lowest price in blister packs of 28 or 120, they comply with rigorous pharmacopeial standards. This pharmaceutical masterpiece must be used under expert medical supervision, ensuring patient safety. Marketed by various reputed companies and distributed widely across India, they offer superior efficacy and reliability.
Application & Competitive Edges of 150 Mg Nilotinib Capsules
The 150 Mg Nilotinib Capsules are specifically designed for adults diagnosed with Philadelphia chromosome positive chronic myeloid leukemia. These prescription-only capsules provide targeted oral therapy, ensuring optimum disease management. Manufactured to top standards, the capsules boast masterful bioavailability and minimal side effects, delivering robust patient outcomes. The usage is exclusive to chronic myeloid leukemia cases, setting a benchmark in competitive advantage among oncology treatments.
Supply Capacity, Payment Process & Handover Details
With a market value that reflects consistent demand, the 150 Mg Nilotinib Capsules are distributed efficiently from reputable exporters and traders in India. Flexible payment terms accommodate various buyers, and valuation aligns with global competitive pricing. Capsules are handed over following strict standards at the designated FOB port, ensuring prompt and secure delivery. Supply ability meets international requirements, making these capsules a preferred choice for importers and distributors alike.
Application & Competitive Edges of 150 Mg Nilotinib Capsules
The 150 Mg Nilotinib Capsules are specifically designed for adults diagnosed with Philadelphia chromosome positive chronic myeloid leukemia. These prescription-only capsules provide targeted oral therapy, ensuring optimum disease management. Manufactured to top standards, the capsules boast masterful bioavailability and minimal side effects, delivering robust patient outcomes. The usage is exclusive to chronic myeloid leukemia cases, setting a benchmark in competitive advantage among oncology treatments.
Supply Capacity, Payment Process & Handover Details
With a market value that reflects consistent demand, the 150 Mg Nilotinib Capsules are distributed efficiently from reputable exporters and traders in India. Flexible payment terms accommodate various buyers, and valuation aligns with global competitive pricing. Capsules are handed over following strict standards at the designated FOB port, ensuring prompt and secure delivery. Supply ability meets international requirements, making these capsules a preferred choice for importers and distributors alike.
FAQ's of 150 Mg Nilotinib Capsules:
Q: How are 150 Mg Nilotinib Capsules administered to patients?
A: These capsules are administered orally and should be taken strictly as prescribed by a qualified healthcare provider, typically for adults with Philadelphia chromosome positive chronic myeloid leukemia.Q: What competitive advantages do Nilotinib Capsules offer compared to other treatments?
A: Nilotinib Capsules are a targeted oral therapy offering masterful disease management with optimum bioavailability. They provide top-notch efficacy and comply with international pharmacopeial standards, setting them apart from many alternatives.Q: When should a patient use Nilotinib Capsules for chronic myeloid leukemia?
A: Patients should use Nilotinib Capsules after consultation and prescription from their oncologist, specifically when diagnosed with Philadelphia chromosome positive chronic myeloid leukemia.Q: Where are 150 Mg Nilotinib Capsules supplied and distributed from?
A: These capsules are widely supplied and distributed by various pharmaceutical companies and suppliers, primarily based out of India, catering to domestic and international markets.Q: What precautions should be taken during the process of using these capsules?
A: Nilotinib Capsules must be used strictly under medical supervision. Patients should adhere to prescribed dosages, avoid exposure to excessive heat or moisture, and report any unusual symptoms to their healthcare provider.Q: What benefits do patients gain by using these capsules?
A: Patients benefit from targeted oral treatment, streamlined administration, and reduced side effects, leading to improved management of chronic myeloid leukemia and enhanced quality of life.
Tell us about your requirement
Price:
Quantity
Select Unit
- 50
- 100
- 200
- 250
- 500
- 1000+
Additional detail
Mobile number
Email
Contact Details
NEETCO BIOPHARMA
GST : 27AJDPC5511A1Z1
- Shop No. 2, Ground Floor, Sr. No-51 Plot No -197, Subham Apartment, Bhairav Nagar, Dhanori,Pune - 411015, Maharashtra, India
- Phone :08071793443
Send Inquiry
Developed and Managed by Infocom Network Private Limited.
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese